Percutaneous RVAD to Preemptively Treat Right Heart Failure Post-LVAD

NCT04458103 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
161
Enrollment
OTHER
Sponsor class

Stopped There were excess adverse events in study population compared to baseline controls

Conditions

Interventions

Sponsor

Massachusetts General Hospital